
The outlook for medical device manufacturing in the coming year

The outlook for medical device manufacturing in the coming year

What medical practices need to know about risk in 2026

How an organization in the Lone Star State aims to make health insurance affordable while promoting market competition.

Token surveys and late-stage consultation undermine trust and lead to worse decisions.

An advocate discusses how ACOs raised red flags about Medicare spending for skin substitute treatments for patient wounds.

How an organization in the Lone Star State aims to make health insurance affordable while promoting market competition.

What medical practices need to know about risk in 2026

The outlook for medical device manufacturing in the coming year

Physicians want input. The problem isn’t apathy — it’s whether leaders are listening and acting.

What medical practices need to know about risk in 2026

How an organization in the Lone Star State aims to make health insurance affordable while promoting market competition.

A negative Net Promoter Score doesn’t just reflect morale — it flags loyalty risk physicians can’t ignore.

An advocate discusses how ACOs raised red flags about Medicare spending for skin substitute treatments for patient wounds.

What medical practices need to know about risk in 2026

The outlook for medical device manufacturing in the coming year

How an organization in the Lone Star State aims to make health insurance affordable while promoting market competition.

The right Roth conversion can save you thousands of dollars in taxes when used correctly

Physicians trust their direct supervisors far more than executive leadership. Bill Heller explains how visibility and proximity shape credibility.

How an organization in the Lone Star State aims to make health insurance affordable while promoting market competition.

What medical practices need to know about risk in 2026

Highly engaged physicians are far more likely to trust leadership — and Bill Heller says transparency and follow-through matter more than grand strategy.

An advocate discusses how ACOs raised red flags about Medicare spending for skin substitute treatments for patient wounds.

An advocate discusses how ACOs raised red flags about Medicare spending for skin substitute treatments for patient wounds.

The outlook for medical device manufacturing in 2026

The outlook for medical device manufacturing in the coming year

CHG Healthcare’s latest survey shows most physicians say they’re satisfied at work, but very few feel truly engaged — a gap that carries real retention risk for practices.

The key to a solid investing plan is using tried-and-true methods.

An advocate discusses how ACOs raised red flags about Medicare spending for skin substitute treatments for patient wounds.

The outlook for medical device manufacturing in the coming year

An advocate discusses how ACOs raised red flags about Medicare spending for skin substitute treatments for patient wounds.